Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The Pediatric Infectious Disease Journal|August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative InfectionJohn S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Clinical Pharmacokinetics|October 5, 2016
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and DolutegravirMatt S Anderson, Sauzanne Khalilieh, Ka Lai Yee, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy SubjectsMatthew L Rizk, Elizabeth G Rhee, Patricia A Jumes, et al.
Pharmaceutical Research|December 3, 2015
Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining FluidPyry A J Välitalo, Koen Griffioen, Matthew L Rizk, et al.
Jac-Antimicrobial Resistance|March 7, 2023
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearanceJason A Roberts, David P Nicolau, Ignacio Martin-Loeches, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionChristopher Lucasti, Liviu Vasile, Dorel Sandesc, et al.
British Journal of Clinical Pharmacology|February 8, 2016
Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluidJ G Coen van Hasselt, Matthew L Rizk, Mallika Lala, et al.
Clinical Pharmacology in Drug Development|June 8, 2019
Pharmacokinetic Interactions Between the Fixed-Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult ParticipantsHwa-Ping Feng, Zifang Guo, Christine Fandozzi, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2018
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection ModelJin Wu, Fred Racine, Michael K Wismer, et al.
Open Forum Infectious Diseases|November 26, 2020
In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas AeruginosaDonna Carr, Zufei Zhang, Qian Si, et al.
Pageof 6